- Price
- $0.69
- Day
- -1.64%
- Mkt Cap
- $108.71M
- 52W Range
- $0.38 – $2.45
- Volume
- 840.4K
- Beta
- 2.33
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Fractyl Health, Inc. (“Fractyl” or the “Company”) (NASDAQ: GUTS) of the October 20, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company.
Read full article
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- SueWallSt reminds purchasers of Fractyl Health, Inc. (NASDAQ: GUTS) securities of a pending securities class action brought on behalf of shareholders who purchased between January 13, 2025 and January 29, 2026.
Read full article
LOS ANGELES, Sept. 07, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 20, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fractyl Health, Inc. (“Fractyl” or the “Company”) (NASDAQ: GUTS) securities between January 13, 2025 and January 29, 2026 inclusive (the “Class Period”).
Read full article
New York, New York--(Newsfile Corp. - September 7, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period").
Read full article
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Fractyl To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Fractyl between January 13, 2025 and January 29, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - September 6, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ: GUTS) and reminds investors of the October 20, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Read full article
New York, New York--(Newsfile Corp. - September 6, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law
Read full article
New class action for GoDaddy (GDDY) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 10/20/2026
Read full article
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fractyl (GUTS) To Contact Him Directly To Discuss Their Options
Read full article
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Fractyl To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Fractyl between January 13, 2025 and January 29, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - September 4, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ: GUTS) and reminds investors of the October 20, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Read full article
NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ: GUTS) and certain officers.
Read full article
Two consecutive trading sessions erased roughly 74.86% of Fractyl Health's share value after the Company reported REMAIN-1 Midpoint Cohort data that the lawsuit alleges corrected earlier statements about Revita DMR's weight-maintenance efficacy. NEW YORK, Sept.
Read full article
BENSALEM, Pa., Sept. 3, 2026 /PRNewswire/ -- The Law Offices of Howard G.
Read full article